|
Imatinib mesylate
- 英文名称：Imatinib mesylate
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B10050
- cas：220127-57-1
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-11-05
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B10050 |
| 用途 | 科研检测 |
| 英文名称 | Imatinib mesylate |
| 包装规格 | 1MG |
| CAS编号 | 220127-57-1 |
| 别名 | Imatinib mesylate |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by TLC,;NMR (Conforms)
分子式:C29H31N7O ? CH3SO3H
分子量:493.62 ? 96.11
溶剂:DMSO (50 mg/ml) Water (50 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):BCR-ABL inhibitor
Function / Pharmacology:Imatinib is a tyrosine kinase inhibitor specific for abl (IC50 = 0.038 μM)1, PDGF-R (IC50 = 0.3 μM)1 and c-kit (IC50 = 0.1 μM)2. It is a clinically useful anti-cancer drug approved for the treatment of chronic myelogenous leukemia, gastrointestinal stromal tumors as well as several other cancers.
分子式:C29H31N7O ? CH3SO3H
分子量:493.62 ? 96.11
溶剂:DMSO (50 mg/ml) Water (50 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):BCR-ABL inhibitor
Function / Pharmacology:Imatinib is a tyrosine kinase inhibitor specific for abl (IC50 = 0.038 μM)1, PDGF-R (IC50 = 0.3 μM)1 and c-kit (IC50 = 0.1 μM)2. It is a clinically useful anti-cancer drug approved for the treatment of chronic myelogenous leukemia, gastrointestinal stromal tumors as well as several other cancers.
